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Abstract
Background: Alternative splicing (AS) is important for evolution and major biological functions in
complex organisms. However, the extent of AS in mammals other than human and mouse is largely
unknown, making it difficult to study AS evolution in mammals and its biomedical implications.
Results: Here we describe a cross-species EST-to-genome comparison algorithm (ENACE) that
can identify novel exons for EST-scanty species and distinguish conserved and lineage-specific
exons. The identified exons represent not only novel exons but also evolutionarily meaningful AS
events that are not previously annotated. A genome-wide AS analysis in human, mouse and rat
using ENACE reveals a total of 758 novel cassette-on exons and 167 novel retained introns that
have no EST evidence from the same species. RT-PCR-sequencing experiments validated ~50 ~80%
of the tested exons, indicating high presence of exons predicted by ENACE. ENACE is particularly
powerful when applied to closely related species. In addition, our analysis shows that the ENACE-
identified AS exons tend not to pass the nonsynonymous-to-synonymous substitution ratio test
and not to contain protein domain, implying that such exons may be under positive selection or
relaxed negative selection. These AS exons may contribute to considerable inter-species functional
divergence. Our analysis further indicates that a large number of exons may have been gained or
lost during mammalian evolution. Moreover, a functional analysis shows that inter-species
divergence of AS events may be substantial in protein carriers and receptor proteins in mammals.
These exons may be of interest to studies of AS evolution. The ENACE programs and sequences
of the ENACE-identified AS events are available for download.
Conclusion: ENACE can identify potential novel cassette exons and retained introns between
closely related species using a comparative approach. It can also provide information regarding
lineage- or species-specificity in transcript isoforms, which are important for evolutionary and
functional studies.
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Background
Alternative splicing (AS) is suggested to be a major source
of transcriptome/proteome complexity and gene function
diversity [1-7], and highly relevant to several human dis-
eases [8-10]. AS is also reported to alter important protein
features, such as phosphorylation, glycosylation, and
transmembrane helices [11]. Bioinformatics studies based
on expressed sequence tag (EST) database estimate that
between 30% and 60% of all human genes undergo AS [1-
3,12,13]. However, the exact extent of AS in the human
genome remains uncertain and EST/mRNA information
in mammals other than human and mouse is still very
limited. Therefore, it is likely that a considerable number
of human AS transcripts remain unknown, and even more
AS variants are to be discovered in other EST-scanty mam-
mals. Moreover, adequate information of AS variants in
more mammalian species other than human and mouse
can further our understanding on the evolution of AS and
its implications in functional divergence. Hence, it is
desirable to identify unannotated AS variants and evolu-
tionarily meaningful AS events in mammals, particularly
in species of which AS events have remained largely undis-
covered.
AS exons are suggested to evolve fast in mammals [14,15].
The high evolution rate of AS exons may have caused
remarkable inter-species divergence of AS patterns, which
in turn can result in different protein structures and func-
tions. To further understand mammalian functional
divergence in view of AS evolution, it is important to ana-
lyze species-specific AS exons (exons that are alternatively
spliced in one species but constitutively spliced in others)
and conserved AS exons (exons that are alternatively
spliced in compared species). Species-specific AS variants
can result in functional novelty by changing the length,
composition, structure, and/or transcriptional and trans-
lational regulation of proteins in the affected species,
leading to remarkable functional disparity between
orthologous proteins [16]. On the other hand, conserved
AS variants represent functionally important transcripts
that tend to preserve such features as length, exon-intron
boundaries, number of exons, reading frame, introns
flanking AS exons, and so on [5,17-21]. In other words,
conserved AS variants serve to form the framework of crit-
ical biological functions across species, while species-spe-
cific AS events constitute a mechanism to develop novel
protein functions that occur only in the affected species.
Therefore, it is important to perform a systematical analy-
sis to identify potential species-specific and conserved AS
events in mammals.
The simplest way of determining species-specificity of AS
events is to check inter-species differences in AS patterns
based on EST information. However, the limited availa-
bility of EST information seriously restricts the applica-
tion of such approaches. In contrast, comparative
computational approaches can circumvent this shortcom-
ing and identify AS events without EST data. Nevertheless,
previous comparative computational studies mainly focus
on identification of cassette-off exons (exons that were
annotated as constitutive, but later found to be alterna-
tive) based on sequence features of conserved AS variants
[18-24]. Meanwhile, cassette-on exons (exons that were
not previously annotated) and retained introns (newly
annotated exonic sequences that cover the full length of
introns) have remained relatively unexplored. Note that
these cassette-on exons and retained introns represent not
only novel AS events but also novel exonic sequences,
which are different from cassette-off exons because the lat-
ter represent novel AS events formed by known exons.
These two AS exon types are important because they can
insert additional amino acids into existing proteins and
potentially can alter the structure and/or function of the
affected proteins. In particular, retained introns may cause
drastic changes by changing the number of exons and
eliminating existing exon-intron boundaries. Therefore, it
is desirable to identify these less studied AS exons and
infer their functional and evolutionary implications in
mammals. With the combination of cassette-on exon,
retained intron, and cassette-off exon, a more complete
view of AS evolution in mammals can be obtained than if
only one of these AS exon types is studied.
In this study, we propose a new cross-species EST-to-
genome approach named ENACE (Extracting Novel Alter-
native splicing variants from Cross-species EST resources),
which extracts novel exonic sequences of one species (the
"target species") from ESTs of another species (the "source
species"). The extracted exons are compared with existing
EST libraries to confirm that they do not overlap any ESTs
of the target species. As three species (human, mouse, and
rat) are considered here, the study consists of six ENACE
identification processes: EH-m, EM-h, EH-r, ER-h, EM-r, and ER-
m, where the uppercase subscript stands for the target spe-
cies and the lowercase subscript for the source species. For
example, EH-m indicates the ENACE process for extracting
human (the target species) novel exonic regions based on
mouse (the source species) ESTs. We denote the ENACE
predicted novel exonic regions as the "ENACE exons".
Here "novel" indicates lack of annotations in public data-
bases (e.g., UCSC or NCBI) or supporting evidence from
the-same-species ESTs for the existence of ENACE exons.
Note that all the ENACE exons are either cassette-on exons
or retained introns. For the novel exons identified, it is of
primary interest to understand their biological and evolu-
tionary significance. Two functional features of ENACE
exons, including potential protein domains and gene
ontology (GO) categories, are analyzed. In addition, two
evolutionary analyses, namely the nonsynonymous-to-
synonymous substitution ratio test (or the KA/KS ratio testBMC Bioinformatics 2006, 7:136 http://www.biomedcentral.com/1471-2105/7/136
Page 3 of 14
(page number not for citation purposes)
[25,26]) and calculation of the conservation level of
ENACE exons among human, mouse, and rat, are per-
formed. Since ENACE is a comparative approach, we are
able to study species-specific exons or exon gain/loss
events that occurred during mammalian evolution by
analyzing ENACE results. The evolutionary implications
of ENACE results are also discussed.
Results and discussion
Outline of the ENACE strategy
ENACE makes use of cross-species EST-to-genome conser-
vation to extract novel exonic sequences in human,
mouse, and rat. The novel exonic sequences identified can
be also regarded as AS events. Figure 1 illustrates the
ENACE design. This study includes six ENACE AS identifi-
cation processes as stated above (Fig. 1A). Here we take
the EH-m process as an example to describe the ENACE sys-
tem. As shown in Figure 1B, the proposed ENACE process
consists of two major steps: 1. identification of novel
exonic regions; and 2. analyses and validation of the AS
variants identified. For the first step, we use the PSEP
annotator [27] to identify mouse EST fragments con-
served in the human genome (see Methods). ESTs thus
obtained are compared with known human transcripts
(including the human UCSC- and RefSeq-annotated
genes/transcripts) and human ESTs. The matching ESTs
that overlap with known human transcripts/ESTs are dis-
carded. Thus, the remaining exonic sequences are defined
as novel exons with EST evidence from a non-human spe-
cies but not from human itself. Note that, see Figure 2A for
an example, ENACE rules that the flanking exons (i.e., em1
and em3) of the newly identified exon (i.e., em2) must
overlap with a known human transcript (i.e., eh1 and eh2)
to avoid false positive detections. Therefore, the ENACE
system can only identify internal exons. In addition, the
ENACE-identified novel exons are either cassette-on exons
(Fig. 2A) or retained introns (Fig. 2B). The extracted cas-
sette-on exons are further processed because the EST-to-
genome matching procedure (i.e. the PSEP annotation
process) requires high level of sequence identity [27],
which may considerably reduce the alignable lengths and
make the annotated cassette-on exons shorter than they
should be. Therefore, the mouse ESTs that support
ENACE-identified cassette-on exons are BLASTed against
the corresponding human introns to obtain the maximal
alignable sequences (see Methods). If the extended
sequences cover the full range of the corresponding
introns, they are annotated as retained introns rather than
cassette-on exons.
The potential novel exonic regions have to pass the fol-
lowing rules: for cassette-on exons, they must be flanked
by AG-GT/AG-GC legal splicing sites (Rule 1); for both
cassette-on exons and retained introns that are located in
coding sequences (CDS), they must not disrupt the read-
ing frame (Rule 2) and must contain no premature stop
codons (Rule 3). Note that a novel exon is referred to as
"located in CDS" (or "ENACE CDS exon") if such an exon
is located in an intron flanked by coding exons of the tar-
get species. On the other hand, if a novel exon is located
between an untranslated region (UTR) and a coding exon,
or between two UTRs, it is referred to as "located in UTR"
(or "ENACE UTR exon").
Exons that pass the three rules mentioned above are fur-
ther analyzed for functional and evolutionary features,
and experimentally validated using RT-PCR-sequencing
(Fig. 1B). The functional analyses include protein domain
analysis and GO classification, whereas the evolutionary
analyses include the KA/KS ratio test and cross-species con-
servation analysis that determines, for example, whether
the identified EH-m exons are conserved in the rat genome
or ESTs. The workflow stated above also applies to the
other five ENACE processes: EM-h, EH-r, ER-h, EM-r, and ER-m.
Novel exonic regions identified by ENACE
The numbers of novel exonic regions identified in the six
ENACE processes are shown in Table 1. More than 5,000
novel exonic regions (the "meta-ENACE exons") are
extracted by ENACE initially, and 925 of them pass the
three filtering rules. Of these 925 ENACE exons, 758 (692
cassette-on exons and 66 retained introns) are located in
CDS, and the other 167 (141 cassette-on exons and 26
retained introns) in UTR (related information is available
[see Additional files 1 and 2]). Note that the number of
identified retained introns is much smaller than that of
cassette-on exons (Table 1). The reason may be that intron
retention is responsible for only a very low percentage (<
3%) of all AS events [24,28] and it exhibits in less than 5%
of all genes [29,30]. On the other hand, it is noteworthy
that the majority of extracted retained introns in CDS do
not pass Rules 2 and 3. A possible explanation is that a
substantial number of retained introns may be derived
from aberrant or artefactual EST data [31]. Nevertheless, it
is also likely that such retained introns have been pre-
served in the source species while lost in the target species,
or they may be gained by the source species after lineage
divergence. Either way, these potential lineage-specific
retained introns may be evolutionarily important because
they may change the number of exons in the affected
genes and may influence expression regulation mecha-
nisms such as nonsense-mediated decay [30]. Meanwhile,
the number of ENACE UTR exons is smaller than that of
ENACE CDS exons because ENACE identifies only inter-
nal exons. Whereas ENACE CDS exons are functionally
important by inserting extra amino acids, ENACE UTR
exons may be critical to transcriptional and translational
regulation [32-34]. Therefore, the large number of novel
exons identified in this study may lead to new findings inBMC Bioinformatics 2006, 7:136 http://www.biomedcentral.com/1471-2105/7/136
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The ENACE analysis process Figure 1
The ENACE analysis process. (A) Six ENACE processes: EH-m, EM-h, EH-r, ER-h, EH-r, EM-r, and ER-m. Arrows indicate mapping of 
ESTs from the source species to the genome of the target species. See text for more details. (B) An example of ENACE proc-
ess for EH-m. ENACE is implemented with two major components: novel exon identification; and analyses and validation of the 
identified protein-coding exons.
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transcriptomics and proteomics studies on the three spe-
cies involved.
In summary, as many as ~80% of meta-ENACE exons
(~4100 exons), which exist in the source species, are
observed to lack canonical splicing signals or have dis-
rupted reading frames or premature stop codons in the
target species. These exons can be regarded specific to the
source species, which may have evolved fast and play a
unique part in evolution by increasing the rate of evolu-
tionary changes [14]. On the other hand, the ENACE
exons (925 exons) represent both newly identified exons
conserved between the target and source species and novel
AS events in the target species. Such novel AS events are
either specific to the target species (species-specific AS) or
they may be conserved between the target and source spe-
cies (conserved AS). The two scenarios can be distin-
guished by using existing tools [19-21] to check whether
these exons also undergo AS in the source species.
Our results also indicate that two major factors, namely
inter-species divergence and EST coverage level, may
determine the number of novel exons identified (both
cassette-on exons and retained introns) in the ENACE sys-
tem. Taking cassette-on exons as an example (Table 1),
although the number of EST entries for human (HGI,
~835,000 entries) is larger than that for mouse (MGI,
~780,000 entries), the number of novel exons identified
in EH-m (116 exons) and EM-h (119 exons) are very close.
Therefore, it is the divergence between human and mouse
(rather than the abundance of EST information) that
determines how many novel exons can be identified in
this case. Another evidence is found in the comparison of
cassette-on exons identified in EH-r (29 exons) and EM-r
(105 exons), in which the same EST data set (RGI) is
applied but EH-r yields a much smaller number of exons
because of the longer divergence time between human
and rat than between mouse and rat. On the other hand,
an example for the influence of EST coverage level can be
seen in the comparison between EH-r and ER-h. Only 29
novel cassette-on exons are identified in EH-r, which is
much smaller than that for ER-h (87 exons), though the
two species involved are the same in the two processes.
The observation indicates that the number of ENACE
exons is positively related to the number of EST entries
available. The same situation is also observed in the differ-
ent results of EM-r (105 exons) and ER-m (374 exons).
Meanwhile, the large number of 374 novel rat exons iden-
tified is noteworthy. It shows the value of this cross-spe-
cies approach because we can identify a considerable
number of novel AS transcripts and exons for a species
that has only limited EST information (such as rat) by
comparing its genomic sequences with the abundant EST
information from a closely related species (e.g. mouse).
Characteristics of ENACE CDS exons
Table 2 shows the basic properties of ENACE CDS exons.
Note that the cassette-on exons are relatively short on
average (the average and median lengths are 86 bp and 63
bp, respectively), which is consistent with previous stud-
ies [20,21,35], but longer than the original source-target
exon matches (44 bp and 33 bp for mean and median,
respectively). On the other hand, we observe that the aver-
age number of ESTs that support the ENACE cassette-on
exons is very close to one (1.3), implying that these exons
are likely to be minor-form in terms of inclusion level
(defined by Modrek and Lee [14]) not only in the target
species but also in the source species. The low number of
average supporting ESTs for ENACE cassette-on exons
does not result from poor EST coverage because compari-
sons based on human ESTs (EM-h and ER-h) also yield sim-
ilarly low numbers of supporting ESTs (1.6 and 1.5,
respectively). It has been suggested that more than 80% of
minor-form exons fail the KA/KS ratio test [36]. Therefore,
most ENACE exons may not be detected by the KA/KS ratio
Two types of novel AS exons identified in this study Figure 2
Two types of novel AS exons identified in this study. Shown 
in the figure is the mapping of a mouse EST to the human 
genome. (A) Cassette-on exon. eh1 and eh2 are well-anno-
tated human exons. em1, em2, and em3 are segments of a 
mouse EST sequence, where em1 and em3 respectively overlap 
with eh1 and eh2, and em2 matches the human intron between 
eh1 and eh2. em2 is therefore identified as a potential novel cas-
sette-on exon of human. (B) Retained intron. The matching 
EST segment is identified as a retained intron, if it covers a 
whole intron between two adjacent human exons.
A 
B 
Mouse EST matches
Human genomic sequence
New exonic region (retained intron)
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Human well-annotated 
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em1 em3 em2BMC Bioinformatics 2006, 7:136 http://www.biomedcentral.com/1471-2105/7/136
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test [25,26] (discussed in a subsequent section). Moreo-
ver, the average sequence identity of ENACE exons with
their orthologous sequence counterpart is 89% (Table 2),
which is lower than the nucleotide identity threshold (at
least 95%) between orthologous exon pairs used in some
computational approaches [20,21]. Therefore, such com-
putational approaches may not appropriately detect
ENACE exons. In short, ENACE provides a unique tool to
identify potential novel exons that cannot be detected by
other approaches. Although it is likely that predicted tran-
scripts supported by a small number of ESTs are splicing
errors, ENACE exons have passed three biological rules
that can significantly reduce such possibility. In addition,
the supporting ESTs for ENACE exons must include at
least three exons, of which the exons flanking the pre-
dicted novel exon must be conserved in a known gene of
the target species. Therefore, most splicing errors should
have been screened out by ENACE processes.
For protein-coding retained introns, it is noteworthy that
the average length of the "new" exons that include ENACE
retained intron and the flanking exons previously anno-
tated is fairly large (766 bp, see Table 2). The reason is that
approximately half of these retained introns are located
either between the first and the second coding exon, or
between the last and the second last coding exons. The
first and the last coding exons are often part of a large exon
that also contains UTRs. Therefore, a newly identified
retained intron serves to connect such a UTR-including
exon and their neighboring coding exon, resulting in a
single large exon. It is also worth noting that six of the
ENACE retained introns connect the exons of originally
two-exon transcripts to make single-exon transcripts (Fig.
2B). Moreover, ENACE retained introns (average length is
115 bp) are significantly shorter than nonretained introns
(average length of human introns is about 3.3 kbp [37]),
which is consistent with previous observations [30,38].
Functional analyses of ENACE CDS exons
Figure 3 illustrates the classification of genes that include
ENACE CDS exons (the "ENACE genes") according to the
three main GO categories (i.e., "molecular function",
"biology process", and "cellular component") and the
percentage of ENACE exons that overlap protein domains.
The GO annotations of HGI, MGI and RGI transcripts are
downloaded from the TIGR database. Figure 3A shows
that HGI, MGI, and RGI transcripts have similar GO sub-
category distributions. Overall, ENACE genes have similar
distribution patterns to those of HGI, MGI, and RGI tran-
scripts. However, lower percentages of ENACE genes are
assigned GO subcategories than HGI, MGI and RGI
because ~50% of ENACE genes are not annotated in the
GO database, indicating that about half of the ENACE
genes are currently unknown in function. In addition, it
appears that the percentages of ENACE genes in each GO
subcategory (X-axis) reflect the EST coverage levels of
HGI, MGI and RGI except in the "transporter activity" sub-
category in "molecular function" (Fig. 3A). Approximately
80% of the ENACE exons in the "transporter activity" sub-
category are associated with "protein carrier activity"
(~60%) or "receptor protein activity" (~20%). The rela-
tively high percentage of ENACE exons in these subcatego-
ries indicate that either a considerable number of protein
carrier and receptor protein AS transcripts have not been
discovered, or inter-species AS divergence is particularly
significant for these protein groups.
For protein domain preservation, as shown in Figure 3B,
the majority of ENACE exons do not overlap any protein
domains according to the INTERPRO annotation [39].
Table 1: Extracting processes and identification results of ENACE
Located in CDS
ENACE 
processes
AS types Meta-ENACE 
exons
Pass Rule 1 Pass Rule 2
Pass Rule 3 
Located in 
UTR* 
ENACE exons 
+
EH-m Cassette-on 270 219 172 92 24 116
Retained intron 38 - 12 5 3 8
EM-h Cassette-on 315 260 208 98 22 120
Retained intron 51 - 18 5 2 7
EH-r Cassette-on 49 44 39 26 3 28
Retained intron 7 - 3 1 1 2
ER-h Cassette-on 328 244 194 85 2 87
Retained intron 59 - 24 1 1 2
EM-r Cassette-on 255 210 169 74 31 105
Retained intron 202 - 65 14 2 16
ER-m Cassette-on 2789 2017 1550 317 59 376
Retained intron 679 - 220 40 17 57
Total 5042 2994 2674 758 167 925
.* Rules 2 and 3 only apply to prediction of coding exons.
c
2 c 2BMC Bioinformatics 2006, 7:136 http://www.biomedcentral.com/1471-2105/7/136
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The finding is consistent with the results of Kriventseva et
al. [15] and Yeo et al[21], who observed that AS tended
not to locate within protein domains. This observation
implies that the addition of ENACE exons to the affected
transcripts may not alter the functional domains in the
original protein architecture. Therefore, the normal func-
tions of the affected proteins can be preserved and at the
same time the newly added sequences may be allowed to
evolve and develop new functions.
Evolutionary analyses of ENACE CDS exons
To probe the evolutionary significances of the ENACE
CDS exons, two analyses are performed: the KA/KS ratio
test and conservation of ENACE exons in the ESTs or
genome of "the third species" (the species other than the
target and source species in this study).
In Figure 4A, it is clear that the majority of ENACE exons
(> ~70%) do not pass the KA/KS ratio test (KA/KS < 1 at the
5% significance level, see Methods) in all ENACE proc-
esses. The observation indicates that most of ENACE
exons are not subject to stringent selective constraint. The
proportion of the ENACE exons that fail the KA/KS ratio
test is much larger than that of overall human-mouse
orthologous exons (only 9.5%) observed by Nekrutenko
et al. [25] The difference can be ascribed to two reasons.
First, ENACE exons are likely minor-form exons both in
the target and the source species. Such exons are suggested
to have higher rates of evolution and may be under
relaxed negative selection or positive selection pressure
[14]. Second, the lengths of ENACE exons tend to be
short. The short lengths of ENACE exons may provide
insufficient information for the KA/KS ratio test to be effec-
tive [25]. In addition, it is worth noting that the percent-
ages of ENACE cassette-on exons that fail the test in EM-r
and ER-m (≥ 90%) are considerably larger than those in the
other four ENACE processes. The reason may be that
rodents have a higher mutation rate than human because
of their shorter generation time [40,41]. Furthermore, the
percentage of ENACE retained introns that fail the test is
also larger than 90%. This is because 54 of the 66 retained
introns are identified from mouse-rat comparisons. In
brief, though the KA/KS ratio test is very powerful in detect-
ing evolutionarily conserved regions, it is not suitable for
identifying short and fast-evolving exonic regions such as
those identified by ENACE.
For the three-species conservation study, we analyze three
cases: Case 1. rat vs. EH-m and EM-h exons; Case 2. mouse
vs. EH-r and ER-h exons; and Case 3. human vs. EM-r and ER-
m  exons (Fig. 4B). For each case, ENACE exons are
assigned to one of three conditions: (A) the exons are con-
served in both the ESTs and the genome of third species,
or (B) they are conserved only in the genome of the third
species; or (C) they are not conserved in the third species.
Note that an ENACE exon is assigned to condition (B)
only when the exon and its flanking exons are all con-
served in the third species. This criterion can reduce the
possibility of non-specific matching between an ENACE
exon and the genome of the third species. Also note that
the ENACE exons in condition (C) can be regarded as
exons specific to the target and source species (data are
available [see Additional file 3]). For example, as shown
in Figure 4B, the proportion of the mouse-rat specific
ENACE exons (61%) is significantly larger than those of
human-mouse and human-rat (~20% for both) specific
ENACE exons (P < 10-22 and P < 10-15 by Fisher's exact
test). The reason is clear: mouse and rat are more closely
related to each other than they are to human. It is note-
worthy that the ~20% of human-mouse (or human-rat)
specific exons probably had existed in the common ances-
tor of human and rodents but were lost in rat (or mouse)
after the divergence between mouse and rat. Meanwhile,
the 61% rodent-specific exons could be either gained or
lost in the rodent lineage after the divergence between
human and rodents. In either case, these lineage-specific
exons may be evolutionarily important in conveying
inter-lineage protein structural or functional divergence.
Also worth noting is the observation that the proportion
of condition (A) ENACE exons in Case 2 (37%) is signifi-
cantly larger than those in both Cases 1 and 3 (P < 10-6
and P < 10-9 by Fisher's exact test). The reason of the dif-
ference between Cases 1 and 2 may be the larger EST cov-
erage in mouse than in rat. Hence a large portion of
human-rat ENACE exons can find matches in mouse ESTs,
while only a relatively small percentage of human-mouse
ENACE exons can find matches in rat ESTs. On the other
Table 2: Properties of ENACE CDS exons (including 6 ENACE 
identifications).
Cassette-on exons
No. of exons identified 692
Average length (bp) 86
Median length (bp) 63
Average number of supporting ESTs 1.3
Average sequence identity with the counterpart (%) 89
Retained introns
No. of exons identified 66
Average length (bp) 766
Average length of retained intron (bp) 115
Average number of supporting ESTs 1.1
Average sequence identity with the counterpart (%) 86
No. of initial exons1 17
No. of terminal exons2 19
No. of single-exon transcripts3 6
The retained introns connect 1 the first and the second (or 2 the last 
and the second last) coding exons of the original transcripts. 3 The 
retained introns connect the exons of originally two-exon transcripts 
to make single-exon transcripts.BMC Bioinformatics 2006, 7:136 http://www.biomedcentral.com/1471-2105/7/136
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Functional analyses of protein-coding ENACE exons Figure 3
Functional analyses of protein-coding ENACE exons. (A) Distribution of ENACE exons and ESTs of Human Gene Index (HGI), 
Mouse Gene Index (MGI) and Rat Gene Index (RGI) over gene ontology subcategories. (B) Proportions of ENACE exons that 
overlap protein domains.
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Evolutionary analyses of protein-coding ENACE exons Figure 4
Evolutionary analyses of protein-coding ENACE exons. (A) Proportions of ENACE exons that do not pass the KA/KS ratio test 
(white area) and those that do (black area). (B) Comparison of conservation of ENACE exons in the third species other than 
the target and source species. Case 1: conservation of EH-m and EM-h exons in rat; Case 2: conservation of EH-r and ER-hexons in 
mouse; Case 3: conservation of EM-r and ER-m exons in human. Black and grey color indicates proportion of ENACE exons con-
served in the ESTs and in the genome (but not in the ESTs) of the third species, respectively. White color represents propor-
tion of ENACE exons that are not conserved in the third species.
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hand, the difference between Cases 2 and Case 3 may be
ascribed partly to the longer divergence time between
human and rodents than that between rodents. Overall,
our results show that ENACE is capable of identifying not
only novel exons but also lineage-specific exons that are
involved in AS events, which makes ENACE a convenient
tool for AS and evolutionary studies.
Experimental validation of ENACE CDS exons
To experimentally test the predicted exons, nine sets of
ENACE CDS exons are chosen for RT-PCR-sequencing val-
idation. These include cassette-on exons from six ENACE
processes, retained introns from human-rodent compari-
sons (EH-m+EM-h+EH-r+ER-h), and retained introns in EM-r
and ER-m (Table 3). An example of RT-PCR results is given
in Figure 5, and the validation results are summarized in
Table 3. Eighty-three percent of ENACE cassette-on exons
from human-mouse comparisons are experimentally vali-
dated. Similarly, 50%, 67%, 75%, and 58% for EH-r, ER-h,
EM-r, and ER-m, respectively, are experimentally verified.
For retained introns, 80% for both human-rodent com-
parisons and EM-r, and 60% for ER-m are validated. Overall,
the experiments indicate that at least 50% of the ENACE
exons tested are observed to be novel exons as well as
novel alternatively spliced exons in tissues of the target
species. These experimental results support the high rates
of presence of ENACE exons (complete results are availa-
ble [see Additional files 4 and 5]).
Conclusion
In this study we identify as many as ~900 novel exons
with a comparative algorithm based on cross-species EST-
to-genome comparisons. These novel exons also represent
novel AS events because they are either cassette-on exons
or retained introns with no previous transcript evidence.
Subsequent experimental validation shows that more
than 50% of the predicted novel exons are actually
included in the transcripts of the target species. The algo-
rithm is different from existing ones because it can iden-
tify exons that will otherwise be omitted in other
approaches such as the ones based on the-same-species
EST information [42-45], computational properties
[20,21], or evolutionary properties (e.g. the KA/KS ratio
test [25,26,46]). In addition, the cross-species approach
has a unique advantage that it can detect AS events and
novel exons for EST-scanty species by applying rich EST
data from a closely related species. The mouse-rat compar-
isons exemplify how mouse ESTs can effectively help
identify AS exons in rat. Furthermore, the ENACE algo-
rithm is capable of identifying species-specific, lineage-
specific and conserved exons, and exons that may be
gained or lost in one of the compared species. These exons
may be interesting targets for evolutionary and biomedi-
cal studies.
Methods
Cross-species EST-to-genome comparison by PSEP
We applied PSEP package [27], which is a cross-species
gene identification and AS recognition system, to extract
cross-species conserved sequences and AS variants. The
PSEP system was implemented in two steps: CRASA-based
sequence alignments [47] for EST-to-genome/genome-to-
genome alignments and a series of progressive signal
extracting and patching for exonic region curation. For the
first step, PSEP aligned genome of the target species (e.g.,
human) against ESTs from the target species (e.g., HGI,
Human Gene Index), ESTs from the source species (e.g.,
MGI, Mouse Gene Index), and genome of the source spe-
cies (e.g., mouse) simultaneously using the CRASA
aligner. After completing sequence alignment, post-align-
ment processes were used to extract exonic regions from
the cross-species EST-to-genome alignments. The post-
alignment processes included three main steps: reduction
of EST-matching results, gap-patching, and analysis of AS
transcripts. For reduction of EST-matching results, a large
amount of overprediction was filtered out with the aid of
Table 3: Experimental verification of ENACE CDS exons.
Cassette-on exons Human vs. mouse Human vs. rat Mouse vs. rat
EH-m EM-h EH-r ER-h EM-r ER-m
No. of ENACE CDS exons 92 98 26 85 74 317
No. of exons for experimental test 12 12 6 12 12 12
No. of verified exons (%) 10 10 3 8 9 7
(83%) (83%) (50%) (67%) (75%) (58%)
Retained introns Human vs. Rodents Mouse vs. rat
(EH-m+EM-h+EH-r+ER-h)E M-r ER-m
No. of ENACE CDS exons 12 14 40
No. of exons for experimental test 5 5 10
No. of verified exons 4 4 6
(80%) (80%) (60%)BMC Bioinformatics 2006, 7:136 http://www.biomedcentral.com/1471-2105/7/136
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conserved sequences identified in the cross-species
genome-to-genome and the EST-to-genome alignments.
For gap-patching, several rules were applied to progres-
sively deal with gaps and mismatches. Gaps may be
patched with reference to high-quality genomic sequence
or the EST hits from cross-species EST-to-genome compar-
isons. For the AS analysis, the patched EST matches, if
judged to be redundant, were eliminated by a redun-
dancy-removing rule. Then some filters were applied to
further screen out potential artifacts (see Ref. [27] for the
detail). The system took account of conserved sequences
between the human genome and non-human (e.g.,
mouse and rat) ESTs, in addition to genome comparison
between the two species. With its dual functions in cross-
species conserved sequence analysis and AS analysis, PSEP
was used here for extracting potentially novel AS patterns
including cassette-on exons and retained introns from
cross-species ESTs.
Extension of aligned sequences and screening of extracted 
cassette-on exons
In the ENACE system, we use the PSEP annotator [27] to
perform EST-to-genome comparisons. Since the PSEP
algorithm requires high level of identity between com-
pared sequences, the lengths of extracted cassette-on
exons can be underestimated. Therefore, we try to extend
the lengths of these exons by BLAST-aligning the support-
ing ESTs against the corresponding introns of the target
An example of experimental results for novel AS transcript identified by the EH-m process Figure 5
An example of experimental results for novel AS transcript identified by the EH-m process. Shown in the figure are RT-PCT 
products of the human KIAA1109 protein (XP_371706) and its mouse homologue. The 225-bp and 426-bp band represents 
the well-documented transcript and the novel AS transcript, respectively. The novel AS transcript is expressed in 2/10 human 
cell lines tested, and in 3/4 mouse cell lines in this study.BMC Bioinformatics 2006, 7:136 http://www.biomedcentral.com/1471-2105/7/136
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species. By doing so, we can obtain maximal alignable
regions between source ESTs and the target genome. After
that, the exon/intron boundaries of the newly annotated
exons are also identified, followed by checking the pres-
ence of reading frame openness and premature stop-
codon. We use the EH-m process as an example to describe
our analysis scheme. Given a new PSEP-extracted exon
em2with its flanking exons em1 and em3 (Fig. 2A), eh1 and
eh2 are well-annotated human exons that overlap with em1
and em3 but not em2. We extracted the human intronic
sequence between eh1 and eh2, and BLAST-aligned this
sequence against the corresponding mouse EST sequence
located between em1 and em3 to obtain the maximal align-
able region. Note that it is possible that the extended
region may finally cover the full length of the intron
between eh1 and eh2 and become a retained intron (Fig.
2B). The maximal alignable regions that are not flanked
by GT-AG or GC-AG canonical splicing signals are not
considered. Finally, the remaining exonic regions with
legal exon/intron boundaries are further checked to filter
out the ones with frame shifts and premature stop codons.
Note that the BLAST package is used with default parame-
ters throughout this study.
Prediction of protein domains
We detected protein domain overlapping of ENACE exons
using the InterProScan package and the INTERPRO
resource [39,48-50]. ENACE exons and their flanking
exonic sequences were concatenated for InterPro domain
scanning.
KA/KS ratio test
We performed the KA/KS ratio analysis of orthologous
exon pairs using the following procedures: (i) calculating
the numbers of synonymous and non-synonymous sites,
KA, KS, and KA/KS values, using the PAML package [51,52];
(ii) creating two-way contingency tables with rows com-
prising numbers of synonymous and non-synonymous
sites and columns comprising numbers of changed and
unchanged sites; and (iii) testing the independence
between the numbers of changed synonymous and non-
synonymous sites using Fisher's exact test.
Experimental validation
Human cDNA was obtained by RT-PCR from the follow-
ing 31 cell lines of 11 different tissue types: stomach
(AZ521), liver (HepG2, HepG2/C3A), muscle (TE671),
cervical (HeLa), lung (H1299, H460, A549), epithelium
(A431, HaCaT), connective tissue (HS-5), embryo (293T),
blood cell (ME1, BV173, MV411, NB4, REH, CEM-VBL,
K562, HL60, HL60-ADR, supB15, 697), colon (HT-29,
LoVo), and nervous tissue (NB5, NB17, PCL4199,
PCL1643, PCL2021, BE2C). Mouse cDNA was obtained
by the same procedure from the following 10 tissue types
(Ambion®-Normal): brain, heart, thymus, lung, liver,
embryo, kidney, spleen, ovary, and testicle; and four cell
lines: adrenal (Y-1), fibroblast (primary culture of embry-
onic fibroblast cell), and blood cell (J774A, RAW264.7).
Rat cDNA was also obtained by RT-PCR from the follow-
ing 10 tissue types (Ambion®-Normal): brain, heart, thy-
mus, lung, liver, embryo, kidney, spleen, ovary, and
testicle. The Taq DNA polymerase kit (Roche®) was used
with primers designed to target flanking exons of the AS
exons to be verified. PCR products of expected sized were
purified using the QIAquick Gel Extraction kit (QIAgen®)
and auto-sequenced.
Data sources
The original EST databases were generously provided by
TIGR (The Institute for Genome Research [53]). The
human, mouse, and rat EST databases used in this study
were HGI (Human Gene Index) Release 15 with 524 Mb
for 835,626 sequences, MGI (Mouse Gene Index) Release
14 with 433 Mb for 777,505 sequences, and RGI (Rat
Gene Index) Release 13 with 101 Mb for 147,056. The
original human, mouse, and rat genomic data were ver-
sions hg17 (or NCBI Human Build 35), mm5 (or NCBI
Mouse Build 33), and rn3 (or NCBI Rat Build 2), respec-
tively. These genomic sequences and the UCSC-annotated
genes/transcripts (including human, mouse, and rat) were
all downloaded from the UCSC genome browser [54].
The NCBI-annotated human, mouse, and rat genes/tran-
scripts (RefSeq) were downloaded at [55]. The InterPro
resource was downloaded at [50]. The ENACE programs
and sequences of the ENACE-identified AS events are
available at [56].
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